Ekso Bionics to Report Second Quarter 2016 Financial Results on July 28, 2016

RICHMOND, Calif., July 26, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it will release financial and business results for the second quarter 2016 after the close of trading on Thursday, July 28, 2016.  The Company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

Investors interested in listening to the conference call may do so by dialing (877) 407-3036 for domestic callers or (201) 378-4919 for international callers, or from the webcast on the “Investor Relations” section of the Company’s website at: www.eksobionics.com.

A replay of the call will be available beginning July 28, 2016 at 4:30 p.m. PT / 7:30 p.m. ET through midnight ET on August 11, 2016.  To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13581989.  The webcast will also be available on the Company’s website for one month following the completion of the call.

About Ekso Bionics
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the Company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities.

The Company is headquartered in the Bay Area and is listed on the OTCQB under the symbol EKSO. For more information, visit: www.eksobionics.com.

Media Contact:
Carrie Yamond / Rajni Dhanjani
212-867-1788
cyamond@lazarpartners.com

Investor Contact:
Debbie Kaster
415-937-5403
investors@eksobionics.com

Source: Ekso Bionics

Released July 26, 2016